exosomes

Phase 2Biologic

GGuangzhou Bio-gene Technology Co., Ltd

exosomes is one of 58 biologic programs targeting Cystitis. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CystitisNot yet recruiting

TreatmentNot yet recruiting

Ocular Surface DiseaseNot yet recruiting

CystitisPhase 1

Not yet recruiting

TreatmentPhase 1

Not yet recruiting

Ocular Surface DiseasePhase 2

Not yet recruiting

Competition

Competitive Landscape

350 competitors in Treatment

#DrugCompanyPhaseTrials

Lamprene

Novartis

Preclinical

1 2

Emtriva

Gilead

Preclinical

1 3

Alfenta

Jazz Pharmaceuticals

Preclinical

1 4

Theo-Dur

Pfizer

Preclinical

1 5

Levulan

Sun Pharmaceutical Industries, Inc.

Preclinical

1 6

exosomes

GGuangzhou Bio-gene Technology Co., Ltd

Phase 2

1 7

Foscavir

CClinigen, Inc.

Preclinical

6 8

Sirturo

WWim Janssens

Preclinical

1 9

Clomid

Ferring

Preclinical

1 10

Aurlumyn

BBTG International Inc.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2028

Phase 1Not yet recruiting

Treatment

NCT06932393

Phase 1Not yet recruiting

Cystitis

NCT07665619

Q2 2029

Phase 2Not yet recruiting

Ocular Surface Disease

NCT07382453

Clinical

Trials by Indication[1]

Ocular Surface Disease1 trial

Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases

Not yet recruiting·—·Phase 2·NCT07382453·30 enrolled

Treatment1 trial

Exosomes for Hairloss Treatment

Not yet recruiting·GGuangzhou Bio-gene Technology Co., Ltd·Phase 1·NCT06932393·18 enrolled

Osteoarthritis1 trial

Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1)

Unknown status·FFrancisco Espinoza·Phase 1·NCT05060107·10 enrolled

Cystitis1 trial

Clinical Efficacy of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Combined With Sodium Hyaluronate Intravesical Instillation in the Treatment of Radiation Cystitis

Not yet recruiting·FFujian Medical University Union Hospital·Phase 1·NCT07665619·48 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for exosomes. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — exosomes compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for exosomes. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Guangzhou Bio-gene Technology Co., Ltd company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 2[1]
Company: GGuangzhou Bio-gene Technology Co., Ltd

exosomes

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2028

Q2 2029

Trials by Indication[1]

Ocular Surface Disease1 trial

Treatment1 trial

Osteoarthritis1 trial

Cystitis1 trial

References

Drug Info

Quick Facts

Related News